Literature DB >> 142432

Pulmonary and extrapulmonary sarcoidosis in relation to circulating immune complexes: a quantification of immune complexes by two radioimmunoassays.

R C Gupta, F Kueppers, R A DeRemee, K A Huston, F C McDuffie.   

Abstract

Serum specimens from 53 patients with pulmonary sarcoidosis were examined for the presence of immune complexes by 2 methods, the Raji cell and the monoclonal rheumatoid factor radioimmunoassays. We found increased concentrations of immune complexes in the sera of 27 patients by one or both techniques. A significant association was found between increased concentrations of immune complexes and stage III sarcoidosis. Seventeen of 23 patients with stage III sarcoidosis and 10 of 50 with stage I or II disease had increased concentrations of immune complexes. Eight of the 10 patients with stage I or II sarcoidosis and increased concentrations of immune complexes had extrapulmonary sarcoid features, such as erythema nodosum, synovitis, or salivary gland enlargements. The size of the immune complex was 15S in one of the patients examined. Concentrations of C4 were normal. The data suggest a possible role of immune complexes in the pathogenesis of pulmonary and extrapulmonary features of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142432     DOI: 10.1164/arrd.1977.116.2.261

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Sarcoidosis and mononuclear phagocytes.

Authors:  J B Gee; P T Bodel; S K Zorn; L M Hinman; C A Stevens; R A Matthay
Journal:  Lung       Date:  1978       Impact factor: 2.584

Review 2.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

3.  Interaction of immune complexes and T suppressor cells in sarcoidosis.

Authors:  J D Williams; M D Smith; B H Davies
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

4.  Circulating immune complexes in sarcoidosis.

Authors:  N M Johnson; M W NcNicol; J E Burton-Kee; J F Mowbray
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

5.  Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort.

Authors:  Basheer Khassawneh; Chengsong Zhu; Briana Barkes; Brian Vestal; Sarah Shrock; May Gillespie; Karin Pacheco; Kevin D Deane; Lisa A Maier; Quan-Zhen Li; Nabeel Hamzeh
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

6.  Immunohistological study of human lungs by immunoperoxidase technique.

Authors:  B Fox; S Shousha; K R James; G C Miller
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

7.  C1q binding activity in the sera of patients with chronic lung diseases.

Authors:  K M Cooper; M Moore; A M Hilton
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

8.  Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.

Authors:  G A Rossi; O Sacco; E Cosulich; G Damiani; G Corte; A Bargellesi; C Ravazzoni
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

9.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.

Authors:  G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections.

Authors:  R I Carr; A K Chakraborty; M J Brunda; P T Davidson; P B Damle; M A Hardtke; K J Gilbride; P Minden
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.